Inicio › Cáncer (todos los tipos) › Texas › Austin
Ensayos clínicos de Cáncer (todos los tipos) en Austin, TX
22 estudios para Cáncer (todos los tipos) buscan participantes en centros de Austin y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
ReclutandoFase 1/2
- NEXT Oncology ( Site 1010), Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
ReclutandoFase 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Texas LLC - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- USO - Texas Oncology, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
ReclutandoFase 3
- Texas Oncology, Austin
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
ReclutandoFase 1
- Urology Austin, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
ReclutandoFase 3
- Urology Austin, LLC, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- Texas Oncology-Austin North /ID# 279958, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
ReclutandoFase 1
- NEXT Oncology, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- NEXT Oncology - Austin, Austin
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Texas Oncology - Central South, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
ReclutandoFase 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
ReclutandoFase 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
ReclutandoFase 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
ReclutandoFase 1/2
- NEXT Oncology Austin, Austin
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX124 estudios
- New York City, NY105 estudios
- Boston, MA90 estudios
- Los Angeles, CA73 estudios
- Nashville, TN65 estudios
- Durham, NC61 estudios
- Washington, DC60 estudios
- Philadelphia, PA57 estudios
- Arlington, VA52 estudios
- Chicago, IL51 estudios
- St. Louis, MO51 estudios
- Atlanta, GA49 estudios
Otros estudios en Austin
- Cáncer de pulmón de células no pequeñas29 estudios
- Obesidad22 estudios
- Sobrepeso19 estudios
- Cáncer metastásico18 estudios
- Cáncer del colon y del recto17 estudios
- Cáncer de ovario17 estudios
- Fallo cardíaco17 estudios
- Cáncer de endometrio15 estudios
- Cáncer de seno15 estudios
- Diabetes tipo 214 estudios
- Cáncer de próstata14 estudios
- Esteatosis hepática13 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.